ECSP088889A - Forma nueva de administración de racecadotril - Google Patents

Forma nueva de administración de racecadotril

Info

Publication number
ECSP088889A
ECSP088889A EC2008008889A ECSP088889A ECSP088889A EC SP088889 A ECSP088889 A EC SP088889A EC 2008008889 A EC2008008889 A EC 2008008889A EC SP088889 A ECSP088889 A EC SP088889A EC SP088889 A ECSP088889 A EC SP088889A
Authority
EC
Ecuador
Prior art keywords
racecadotril
administration
new form
tablets
processes
Prior art date
Application number
EC2008008889A
Other languages
English (en)
Inventor
Jean-Charles Schwartz
Jeanne-Marie Lecomte
Original Assignee
Bioprojet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37552919&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP088889(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ
Publication of ECSP088889A publication Critical patent/ECSP088889A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se relaciona con una formulación nueva de racecadotril en la forma de tabletas, con procesos para su preparación y con su uso para tratar la diarrea
EC2008008889A 2006-05-15 2008-11-14 Forma nueva de administración de racecadotril ECSP088889A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0604302A FR2900823B1 (fr) 2006-05-15 2006-05-15 Nouvelle forme d'administration du racecadotril.

Publications (1)

Publication Number Publication Date
ECSP088889A true ECSP088889A (es) 2009-01-30

Family

ID=37552919

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2008008889A ECSP088889A (es) 2006-05-15 2008-11-14 Forma nueva de administración de racecadotril

Country Status (28)

Country Link
US (1) US8318203B2 (es)
EP (1) EP2018158B1 (es)
KR (1) KR101432116B1 (es)
CN (2) CN103961328A (es)
AP (1) AP2627A (es)
AU (1) AU2007251471B2 (es)
BR (1) BRPI0710405B8 (es)
CA (1) CA2652023C (es)
CY (1) CY1114190T1 (es)
DK (1) DK2018158T3 (es)
EA (1) EA014707B1 (es)
EC (1) ECSP088889A (es)
ES (1) ES2421929T3 (es)
FR (1) FR2900823B1 (es)
HR (1) HRP20130624T1 (es)
IL (1) IL195270A (es)
MA (1) MA30466B1 (es)
MX (1) MX2008014554A (es)
NO (1) NO342977B1 (es)
NZ (1) NZ573424A (es)
PL (1) PL2018158T3 (es)
PT (1) PT2018158E (es)
RS (1) RS52912B (es)
SI (1) SI2018158T1 (es)
TN (1) TNSN08428A1 (es)
UA (1) UA98299C2 (es)
WO (1) WO2007132091A1 (es)
ZA (1) ZA200809721B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102018707A (zh) * 2010-11-29 2011-04-20 昆明邦宇制药有限公司 一种治疗腹泻的药物组合物及其制剂
CN102133186B (zh) * 2011-03-18 2012-08-01 海南美大制药有限公司 一种消旋卡多曲脂质体固体制剂
CN102166197B (zh) * 2011-04-25 2012-09-05 四川百利药业有限责任公司 消旋卡多曲颗粒及其生产工艺
JP2013180961A (ja) * 2012-02-29 2013-09-12 Astellas Pharma Inc Ｗｓ７２７７１３含有固形製剤
JP6282645B2 (ja) * 2012-06-28 2018-02-21 ジヨンソン・アンド・ジヨンソン・コンシユーマー・インコーポレーテツドＪｏｈｎｓｏｎ ＆ Ｊｏｈｎｓｏｎ Ｃｏｎｓｕｍｅｒ Ｉｎｃ． ラセカドトリル脂質組成物
US9801819B2 (en) * 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
TR201801726T4 (tr) * 2012-12-26 2018-03-21 Ilko Ilac Sanayi Veticaret A S Rasekadotri̇l ve farmasöti̇k bi̇leşi̇mleri̇.
JP2017500355A (ja) * 2013-12-23 2017-01-05 ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッド ラセカドトリル組成物
MA39009A (fr) 2014-03-10 2015-09-16 Galenicum Health Sl Compositions pharmaceutiques comprenant un agent actif
EP2949318A1 (en) 2014-05-26 2015-12-02 Galenicum Health S.L. Pharmaceutical compositions comprising racecadotril
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril
JP6851973B2 (ja) * 2015-02-09 2021-03-31 リボファーム・エスエーＲｉｖｏｐｈａｒｍ Ｓａ ラセカドトリルの医薬製剤
CN106822907B (zh) * 2016-12-29 2021-02-09 山东达因海洋生物制药股份有限公司 一种含消旋卡多曲的双相释放制剂及其制备方法
ES2978020T3 (es) * 2017-03-06 2024-09-04 Athena Pharmaceutiques Sas Una composición farmacéutica que comprende Racecadotrilo y procedimiento de preparación de la misma

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401677A (en) * 1981-10-09 1983-08-30 E. R. Squibb & Sons, Inc. Enkephalinase inhibitors
GB0015490D0 (en) * 2000-06-23 2000-08-16 Smithkline Beecham Lab Novel formulations
ES2247163T3 (es) 2000-06-23 2006-03-01 Bioprojet Formulacion en polvo seca que comprende racedotril.
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
US20040253305A1 (en) * 2003-06-12 2004-12-16 Luner Paul E. Pharmaceutical compositions of atorvastatin
US20050027012A1 (en) * 2003-07-16 2005-02-03 Boehringer Ingelheim International Gmbh Tablets containing ambroxol
EP1563848A1 (en) 2004-02-12 2005-08-17 Bioprojet New combinations of an anti-emetic agent and an enkephalinase inhibitor
EP1781260B2 (en) * 2004-08-13 2014-04-02 Boehringer Ingelheim International GmbH Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome

Also Published As

Publication number Publication date
KR20090017593A (ko) 2009-02-18
AP2008004686A0 (en) 2008-12-31
FR2900823B1 (fr) 2009-02-13
CY1114190T1 (el) 2016-08-31
KR101432116B1 (ko) 2014-08-21
US20090186084A1 (en) 2009-07-23
EP2018158B1 (fr) 2013-04-24
CN103961328A (zh) 2014-08-06
MA30466B1 (fr) 2009-06-01
US8318203B2 (en) 2012-11-27
ES2421929T3 (es) 2013-09-06
FR2900823A1 (fr) 2007-11-16
IL195270A (en) 2016-08-31
BRPI0710405A2 (pt) 2011-08-09
PL2018158T3 (pl) 2013-09-30
WO2007132091A1 (fr) 2007-11-22
CA2652023C (fr) 2016-06-28
AP2627A (en) 2013-03-26
EA014707B1 (ru) 2011-02-28
ZA200809721B (en) 2009-06-24
AU2007251471A1 (en) 2007-11-22
DK2018158T3 (da) 2013-07-22
UA98299C2 (ru) 2012-05-10
RS52912B (sr) 2014-02-28
HRP20130624T1 (en) 2013-08-31
NO20084826L (no) 2008-12-12
BRPI0710405B8 (pt) 2021-05-25
SI2018158T1 (sl) 2013-09-30
MX2008014554A (es) 2008-11-27
NO342977B1 (no) 2018-09-17
CN101442990A (zh) 2009-05-27
CA2652023A1 (fr) 2007-11-22
AU2007251471B2 (en) 2012-03-15
EA200802324A1 (ru) 2009-04-28
NZ573424A (en) 2012-03-30
PT2018158E (pt) 2013-07-24
BRPI0710405B1 (pt) 2019-01-08
EP2018158A1 (fr) 2009-01-28
TNSN08428A1 (fr) 2010-04-14
IL195270A0 (en) 2009-08-03

Similar Documents

Publication Publication Date Title
ECSP088889A (es) Forma nueva de administración de racecadotril
CL2007002967A1 (es) Forma cristalina a del compuesto 4-[3-(4-ciclopropancarbonil-piperazin-1-carbonil)-4-fluoro-bencil]-2h-ftalazin-1-ona; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de un
UY32456A (es) Composicion famaceutica, forma farmaceutica, procedimiento para su preparación, metodos de tratamiento
SV2009003098A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
AR077199A1 (es) Composicion farmaceutica y procedimiento de tratamiento para la anticoncepcion de emergencia
BRPI0821732A2 (pt) Formulações de liberação controlada , forma de dosagem sólida, e, uso da formulação de liberação controlada
CL2011000214A1 (es) Composicion farmaceutica que comprende progesterona micronizada y aceite de cartamo tipo ii; y uso para el tratamiento de una condicion relacionada con la insuficiencia de secrecion de progesterona.
ECSP10010295A (es) Formulacion de anticuerpo
CR20120283A (es) Inhibidor de bromodominio de benzodiazepina
BRPI0913822A2 (pt) forma farmacêutica oral e uso da forma farmacêutica
NI201100079A (es) Forma de dosificación oral de acetaminofen/tramadol de liberación prolongada
DOP2011000354A (es) Composiciones sublinguales de dexmedetomidina y metodos de uso de ellas
CL2008000510A1 (es) Compuestos conjugados farmaco-ligandos, que se unen a citotoxinas potentes; composicion farmaceutica; y uso para retardar o detener el crecimiento de un tumor en un mamifero.
AU308855S (en) Camera
UY31765A (es) Dihidropirazolonas sustituidas y su uso
UY31922A (es) Compuestos
UY32052A (es) 5-aminopirazoles sustituidos y uso de los mismos
BRPI0815821A2 (pt) Composições e métodos que empregam antagonistas nmda para alcançar um efeito poupador de anestésico.
GT201200304A (es) Composiciones farmacéuticas que comprenden hidromorfona y naloxona
CL2009001841A1 (es) Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto.
CL2012001757A1 (es) Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica; y su uso en el tratamiento de infecciones micoticas.
AR082215A1 (es) Composicion farmaceutica agradable al paladar
CL2012003265A1 (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de enfermedades infecciosas; composicion farmacéutica y/o dermocosmética antiinflamatoria que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo.
ECSP10010711A (es) 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
DOP2010000361A (es) Dronedarona para la prevencion de la cardioversion